Precision BioSciences is developing mulitple DNE therapeutics targeted to enable the precise in situ correction of genes responsible for human disease.
More about BioTherapeutics
Engineered DNE meganucleases are being used to engineer cell lines for disease models or optimize cell lines for the biomanufacturing of protein vaccines and therapeutics.
More about BioTools
Custom DNE meganucleases produced by Precision BioSciences enable site-specific engineering of row crops and biofuel feedstocks.
More about PlantSciences
Recent News:
06.16.2010
US Patent Office Action Rejects All Claims Asserted by Cellectis
04.26.2010
Precision BioSciences Announces Successful Results and Extension with Bayer CropScience
Featured Publication:
04.06.2010
Precision BioSciences and DuPont Detail Technology Efficacy in The Plant Journal
